2023
Entrant Company
Category
Client's Name
Country / Region
Unlocking the Proteome -The NULISA™ Platform sets a new standard in proteomic analysis with attomolar sensitivity, allowing for unprecedented biomarker detection and quantitation.
By leveraging a proprietary sequential immunocomplex capture and release mechanism and the latest advances in Next Generation Sequencing (NGS), the NULISA technology provides both ultra-high sensitivity and scalable multiplexing.
Credits
Entrant Company
LiFi Media Production, LLC
Category
Video - Corporate
Country / Region
United States
Entrant Company
The Garden Creative
Category
Video - Nonprofit
Country / Region
United States
Entrant Company
300FeetOut
Category
Website - Biotechnology
Country / Region
United States
Entrant Company
PPK
Category
Branded Content - Game / Application
Country / Region
United States